{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:32:12Z","timestamp":1791484332449,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/s00115-006-2131-x","type":"journal-article","created":{"date-parts":[[2006,8,21]],"date-time":"2006-08-21T11:40:56Z","timestamp":1156160456000},"page":"264-271","source":"Crossref","is-referenced-by-count":33,"title":["Die Benzamide Tiaprid, Sulpirid und Amisulprid in der Therapie des Tourette-Syndroms","The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette\u2019s syndrome"],"prefix":"10.1007","volume":"78","author":[{"given":"K. R.","family":"M\u00fcller-Vahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"2131_CR1","unstructured":"American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text revision (DSM-IV-TR). APA, Washington"},{"key":"2131_CR2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2004-827171","volume":"37","author":"Bock","year":"2005","unstructured":"Bock N, Moll GH, Wicker M et al. (2005) Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system. Pharmacopsychiatry 37:163\u2013167","journal-title":"Pharmacopsychiatry"},{"key":"2131_CR3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1176\/ajp.136.3.317","volume":"136","author":"Caine","year":"1979","unstructured":"Caine ED, Polinsky RJ, Kartzinel R et al. (1979) The trial use of clozapine for abnormal involuntary movement disorders. Am J Psychiatry 136:317\u2013320","journal-title":"Am J Psychiatry"},{"key":"2131_CR4","first-page":"725","volume":"58","author":"Chouza","year":"1982","unstructured":"Chouza C, Romero S, Lorenzo J et al. (1982) Clinical trial of tiapride in patients with dyskinesia. Sem Hop 58:725\u2013733","journal-title":"Sem Hop"},{"key":"2131_CR5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00449911","volume":"237","author":"Eggers","year":"1988","unstructured":"Eggers C, Rothenberger A, Berghaus U (1988) Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. Eur Arch Psychiatry Neurol Sci 237:223\u2013239","journal-title":"Eur Arch Psychiatry Neurol Sci"},{"key":"2131_CR6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1345\/aph.1D497","volume":"38","author":"Fountoulakis","year":"2004","unstructured":"Fountoulakis KN, Iacovides A, Kaprinis GS (2004) Successful treatment of Tourette\u2019s disorder with amisulpride. Ann Pharmacother 38:901","journal-title":"Ann Pharmacother"},{"key":"2131_CR7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1017\/S0012162200000839","volume":"42","author":"Freeman","year":"2000","unstructured":"Freeman RD, Fast DK, Burd L et al. (2000) An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 42:436\u2013447","journal-title":"Dev Med Child Neurol"},{"key":"2131_CR8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/hup.470080505","volume":"8","author":"George","year":"1993","unstructured":"George MS, Trimble MR, Robertson MM (1993) Fluvoxamine and sulpiride in comorbid obsessive-compulsive disorder and Gilles de la Tourette syndrome. Hum Psychopharmacol 8:327\u2013334","journal-title":"Hum Psychopharmacol"},{"key":"2131_CR9","first-page":"19","volume":"9","author":"Gilles","year":"1885","unstructured":"Gilles de la Tourette G (1885) Etude sur une affection nerveuse caracterisee par de l\u2019incoodination motrice accompagnee d\u2019echolalie et de coprolalie. Arch Neurol 9:19\u201342","journal-title":"Arch Neurol"},{"key":"2131_CR10","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMra010032","volume":"345","author":"Jankovic","year":"2001","unstructured":"Jankovic J (2001) Tourette\u2019s syndrome. N Engl J Med 345:1184\u20131192","journal-title":"N Engl J Med"},{"key":"2131_CR11","first-page":"516","volume":"Psychol","author":"Klepel","year":"1988","unstructured":"Klepel H, Gebelt H, Koch RD et al. (1988) Treatment of extrapyramidal hyperkineses in childhood with tiapride. Psychiatr Neurol Med Psychol (Leipz) 40:516\u2013522","journal-title":"Psychiatr Neurol Med"},{"key":"2131_CR12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00128072-200103050-00004","volume":"3","author":"Kossoff","year":"2001","unstructured":"Kossoff EH, Singer HS (2001) Tourette syndrome: clinical characteristics and current management strategies. Paediatr Drugs 3:355\u2013363","journal-title":"Paediatr Drugs"},{"key":"2131_CR13","first-page":"695","volume":"59","author":"Lipcsey","year":"1983","unstructured":"Lipcsey A (1983) Gilles de la Tourette\u2019s disease. Sem Hop 59:695\u2013696","journal-title":"Sem Hop"},{"key":"2131_CR14","first-page":"292","volume":"40","author":"Mason","year":"1998","unstructured":"Mason A, Banerjee S, Eapen V et al. (1998) The prevalence of Tourette syndrome in a mainstream school population. Dev Med Child Neurol 40:292\u2013296","journal-title":"Dev Med Child Neurol"},{"key":"2131_CR15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/mds.20218","volume":"19","author":"Meisel","year":"2004","unstructured":"Meisel A, Winter C, Zschenderlein R et al. (2004) Tourette syndrome: efficient treatment with ziprasidone and normalization of body weight in a patient with excessive weight gain under tiapride. Mov Disord 19:991\u2013992","journal-title":"Mov Disord"},{"key":"2131_CR16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1517\/14656566.3.7.899","volume":"3","author":"M","year":"2002","unstructured":"M\u00fcller-Vahl KR (2002) The treatment of Tourette\u2019s syndrome: current opinions. Expert Opin Pharmacother 3:899\u2013914","journal-title":"Expert Opin Pharmacother"},{"key":"2131_CR17","unstructured":"M\u00fcller-Vahl K, Kaufmann J, Dengler R et al. (2004) Frontal white matter abnormalities in Tourette Syndrome as detected by voxel-based morphometry and magnetization transfer imaging. Nervenarzt 75(Suppl\u00a02):S230"},{"key":"2131_CR18","first-page":"a","volume":"syndrome","author":"M","year":"2004","unstructured":"M\u00fcller-Vahl KR, Geomelas M, Makowski L et al. (2004) Clinical Symptoms in Tourette syndrome: a prospective study in 480 patients. Poster abstracts. 4th International Scientific Symposium on Tourette-Syndrome, Cleveland, Ohio","journal-title":"Clinical Symptoms in Tourette"},{"key":"2131_CR19","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1212\/01.WNL.0000086370.10186.7C","volume":"61","author":"Pappert","year":"2003","unstructured":"Pappert EJ, Goetz CG, Louis ED et al. (2003) Objective assessments of longitudinal outcome in Gilles de la Tourette\u2019s syndrome. Neurology 61:936\u2013940","journal-title":"Neurology"},{"key":"2131_CR20","unstructured":"Peterson BS, Cohen DJ (1998) The treatment of Tourette\u2019s syndrome: multimodal, developmental intervention. J Clin Psychiatry 59(Suppl\u00a01):62\u201372"},{"key":"2131_CR21","doi-asserted-by":"crossref","unstructured":"Robertson MM (2000) Tourette syndrome, associated conditions and the complexities of treatment. Brain 123(Pt\u00a03):425\u2013462","DOI":"10.1093\/brain\/123.3.425"},{"key":"2131_CR22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00002826-199006000-00005","volume":"13","author":"Robertson","year":"1990","unstructured":"Robertson MM, Schnieden V, Lees AJ (1990) Management of Gilles de la Tourette syndrome using sulpiride. Clin Neuropharmacol 13:229\u2013235","journal-title":"Clin Neuropharmacol"},{"key":"2131_CR23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1517\/14728214.10.2.365","volume":"10","author":"Silay","year":"2005","unstructured":"Silay YS, Jankovic J (2005) Emerging drugs in Tourette syndrome. Expert Opin Emerg Drugs 10:365\u2013380","journal-title":"Expert Opin Emerg Drugs"},{"key":"2131_CR24","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/1531-8257(200011)15:6<1051::AID-MDS1001>3.0.CO;2-L","volume":"15","author":"Singer","year":"2000","unstructured":"Singer HS (2000) Current issues in Tourette syndrome. Mov Disord 15:1051\u20131063","journal-title":"Mov Disord"},{"key":"2131_CR25","first-page":"163","volume":"85","author":"Singer","year":"2001","unstructured":"Singer HS, Wendlandt JT (2001) Neurochemistry and synaptic neurotransmission in Tourette syndrome. Adv Neurol 85:163\u2013178","journal-title":"Adv Neurol"},{"key":"2131_CR26","first-page":"175","volume":"19","author":"Trillet","year":"1990","unstructured":"Trillet M, Moreau T, Dalery J et al. (1990) Treatment of Gilles de la Tourette\u2019s disease with amisulpiride. Presse Med 19:175","journal-title":"Presse Med"},{"key":"2131_CR27","first-page":"439","volume":"59","author":"Yvonneau","year":"1970","unstructured":"Yvonneau M, Bezard P (1970) Apropos of a case of Gilles de la Tourette\u2019s disease blocked by sulpiride. Psycho-biological study. Encephale 59:439\u2013459","journal-title":"Encephale"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-006-2131-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-006-2131-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-006-2131-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T05:00:50Z","timestamp":1558587650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-006-2131-x"}},"subtitle":["Eine Standortbestimmung"],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["2131"],"URL":"https:\/\/doi.org\/10.1007\/s00115-006-2131-x","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}